The U.S. Food and Drug Administration (FDA) has approved the first drug to treat peanut allergy in children. The remedy, Palforzia, mitigates allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. According to an FDA news release, treatment with Palforzia may begin in individuals ages 4 through 17 years with a confirmed… Continue reading Peanut Allergy: A New Medication for Children